Developmental effects of ethinylestradiol on reproductive organs of female mice

In Vivo

Volumn 20, Issue 6, 2006, Pages 867-874

  Kirigaya, Akiko ^a   Hayashi, Shinji ^a   Iguchi, Taisen ^b,c   Sato, Tomomi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b GRADUATE UNIVERSITY FOR ADVANCED STUDIES   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Ethinylestradiol; Fetus; Polyovular follicles; Vagina

Indexed keywords

DIETHYLSTILBESTROL; ETHINYLESTRADIOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM; FEMALE; FEMALE GENITAL SYSTEM; FETOTOXICITY; FETUS; GESTATION PERIOD; MALE; MOUSE; MOUSE STRAIN; NEWBORN; NONHUMAN; OVARIECTOMY; OVARY FOLLICLE; PRENATAL EXPOSURE; REPRODUCTIVE TOXICITY; SURVIVAL RATE; VAGINA EPITHELIUM;

EID: 33846087932     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. DeCherney A: Bone-sparing properties of oral contraceptives. Am J Obstet Gynecol 174: 15-20, 1996.
2. Kaunitz AM: Oral contraceptive health benefits: perception versus reality. Contraception 59: 29S-33S, 1999.
3. Poel WE: Pituitary tumors in mice after prolonged feeding of synthetic progestins. Science 154: 402-403, 1966.
4. IARC monogr. Eval Carcinog Risk Chem Hum Ethynyloestradiol 21: 233-255, 1974.
5. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, Hennekens C, Rosner B and Speizer FE: The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 332: 1589-1593, 1995.
6. Ursin G, Peters RK, Henderson BE, d'Ablaining III G, Monroe ICR and Pike MC: Oral contraceptive use and adenocarcinoma of the cervix. Lancet 344: 1390-1394, 1994.
7. Branham WS, Zehr DR, Chen JJ and Sheehan DM: Uterine abnormalities in rats exposed neonatally to diethylstilbestrol, ethinylestradiol, or clomiphene citrate. Toxicology 51: 201-212, 1988.
8. Newboid RR and Liehr JG: Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Res 60: 235-237, 2000.
9. Holtzman S, Stone JP and Shellabarger C J: Synergism of estrogens and X-rays in mammary carcinogenesis in female ACI rats. J Natl Cancer Inst 67: 455-459, 1981.
10. Yasuda Y, Kihara T and Nishimura H: Effect of prenatal treatment with ethinyl estradiol on the mouse uterus and ovary. Am J Obstet Gynecol 127: 832-836, 1977.
11. Yasuda Y, Kihara T and Nishimura H: Transplacental effect of ethinyl estradiol on mouse vaginal epithelium. Dev Growth Differ 19: 241-247, 1977.
12. Yasuda Y, Kihara T and Nishimura H: Effect of ethinyl estradiol on development of mouse fetuses. Teratology 32: 233-239, 1981.
13. Yasuda Y, Kihara T, Tanimura T and Nishimura H: Gonadal dysgenesis induced by prenatal exposure to ethinyl estradiol in mice. Teratology 32: 219-227, 1985.
14. Yasuda Y, Kihara T and Tanimura T: Ovarian follicular cell hyperplasia in fetal mice treated transplacentally with ethinyl estradiol. Teratology 36: 35-43, 1987.
15. Takasugi N: Cytological basis for permanent vaginal changes in mice treated neonatally with steroid hormones. Int Rev Cytol 44: 193-224, 1976.
16. Forsberg J-G: Developmental mechanism of estrogen-induced irreversible changes in the mouse cervicovaginal epithelium. Natl Cancer Inst Monogr 51: 41-56, 1979.
17. McLachlan JA, Newbold RR and Bullock BC: Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol. Cancer Res 40: 3988-3999, 1980.
18. Forsberg J-G and Kalland T: Neonatal estrogen treatment and epithelial abnormalities in the cervicovaginal epithelium of adult mice. Cancer Res 41: 721-734, 1981.
19. Newbold RR and McLachlan JA: Vaginal adenosis and adenocarcinoma in mice exposed prenatally to diethylstilbestrol. Cancer Res 42: 2003-2011, 1982.
20. Ignchi T: Cellular effects of early exposure to sex hormones and antihormones. Int Rev Cytol 139: 1-57, 1992.
21. Iguchi T: Occurrence of polyovular follicles in ovaries of mice treated neonatally with diethylstilbestrol. Proc Japan Acad 61: 288-291, 1985.
22. Couse JF, Dixon D, Yates M, Moore AB, Ma L, Maas R and Korach KS: Estrogen receptor-α knockout mice exhibit resistance to the developmental effects of neonatal diethylstilbestrol exposure on the female reproductive tract. Dev Biol 238: 224-238, 2001.
23. Laws SC, Carey SA, Ferrell JM, Bodman GJ and Cooper RL: Estrogenic activity of octylphenol, nonyphenol, bisphenol A and methoxychlor in rats. Toxicol Sci 54: 154-167, 2000.
24. Iguchi, T, Takasugi N, Bern HA and Mills KT: Frequent occurrence of polyovular follicles in ovaries of mice exposed neonatally to diethylstilbestrol. Teratology 34: 29-35, 1986.
25. Newbold RR, Bullock BC and McLachlan JA: Exposure to diethylstilbestrol during pregnancy permanently alters the ovary and oviduct. Biol Med 28: 735-744, 1983.
26. Iguchi T, Ohta Y, Fukazawa Y and Takasugi N: Strain differences in the induction of polyovular follicles by neonatal treatment with diethylstilbestrol in mice. Med Sci Res 15: 1407-1407, 1987.
27. Iguchi T, Fukazawa Y, Uesugi Y and Takasugi N: Polyovular follicles in mouse ovaries exposed neonatally to diethylstilbestrol in vivo and in vitro. Biol Reprod 43: 478-484, 1990.
28. Iguchi T, Kamiya K, Uesugi Y, Sayama K and Takasugi N: In vitro fertilization of oocytes from polyovular follicles in mouse ovaries exposed neonatally to diethylstilbestrol. In Vivo 5: 359-363, 1991.
29. Jefferson WN, Couse JF, Padilla-Banks E, Korach KS and Newbold RR: Neonatal exposure to genistein induces estrogen receptor (ER)α expression and multioocyte follicle in the maturing mouse ovary: Evidence for ERβ-mediated and nonestrogenic actions. Biol Reprod 67: 1285-1296, 2002.
30. Fitzpatrick SL, Funkhouser JM, Sindoni DM, Stevis PE, Deecher DC, Bapat AR, Merchenthaler I and Frail DE: Expression of estrogen receptor-β protein in rodent ovary. Endocrinology 140: 2581-2591, 1999.
31. Jefferson WN, Couse JF, Padilla-Banks E, Korach KS and Newbold RR: Expression of estrogen receptor β is developmentally regulated in reproductive tissues of male and female mice. Biol Reprod 62: 310-317, 2000.
32. Lemmen JG, Broekhof JLM, Kuiper GGJM, Gustafsson J-Å, van der Saag PT and van der Burg B: Expression of estrogen receptor alpha and beta during mouse embryogenesis. Mec Dev 81: 163-167, 1999.
33. Jefferson W, Newbold R, Padilla-Banks E and Pepling M: Neonatal genistein treatment alters ovarian differentiation in the mouse: inhibition of oocyte nest breakdown and increased oocyte survival. Biol Reprod 74: 161-168, 2006.
34. Pepling ME and Spradling AC: Mouse ovarian germ cell cysts undergo programmed breakdown to form primordial follicles. Dev Biol 234: 339-351, 2001.
35. Suzuki A, Sugihara A, Uchida K, Sato T, Ohta Y, Katsu Y, Watanabe H and Iguchi T: Developmental effects of perinatal exposure to bisphenol-A and diethylstilbestrol on reproductive organs in female mice. Reprod Toxicol 16: 107-116, 2002.
36. Ashby J, Owens W, Odum J and Tinwell H: The intact immature rodent uterotrophic bioassay: Possible effects on assay sensitivity of vomeronasal signals from male rodents and strain differences. Env Health Perspect 111: 1568-1570, 2003.
37. Spearow JL, O'henley P, Doemeny P, Sera R, Leffler R, Solos T and Barkley M: Genetic variation in physiological sensitivity to estrogen in mice. APMIS 109: 356-364, 2001.